Top Markets
Coin of the day
Eurobio Scientific Société anonyme Eurobio Scientific Société anonyme

Eurobio Scientific Société anonyme

ALERS
株式のランク #10859
Eurobio Scientific Société anonyme designs, develops, and commercializes... Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
株価
$25.15
時価総額
$253.18M
変化(1日)
0.00%
変化(1年)
-12.08%
FR
取引 Eurobio Scientific Société anonyme (ALERS)

カテゴリー

Eurobio Scientific Société anonyme(ALERS)の発行済株式数
December 2025 時点の発行済株式数 10.42M
Eurobio Scientific Société anonyme の最新の財務報告および株価によると、現在の発行済株式数は 10.42M です。December 2023 の終わりには、同社は 11.15M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Eurobio Scientific Société anonyme(ALERS)の発行済株式数の履歴(2007 ~ 2026)
各年末時点の発行済株式数
発行済株式数 変化
2026 (TTM) 10.42M 1.70%
2024 10.25M -8.11%
2023 11.15M 9.08%
2022 10.22M -5.75%
2021 10.85M -3.21%
2020 11.21M 2.74%
2019 10.91M 11.34%
2018 9.80M 11.70%
2017 8.77M 124.58%
2016 3.91M 9.99%
2015 3.55M 14.55%
2014 3.10M 8.91%
2013 2.85M 58.37%
2012 1.80M 4.14%
2011 1.73M 4.32%
2010 1.65M 17.58%
2009 1.41M 5.06%
2008 1.34M 4.74%
2007 1.28M 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数
1.75B 16,660.62%
US
382.90M 3,573.61%
US
1.28B 12,194.92%
IE
1.48B 14,146.38%
US
579.20M 5,456.94%
US